List of WHO guideline Steering Group members

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. Geneva: World Health Organization; 2014.

Cover of The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis

The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance.

Show details

Contents

< Prev Next >

Annex 1List of WHO guideline Steering Group members

Global TB Programme

Dennis Falzon
Haileyesus Getahun
Malgosia Grzemska
Ernesto Jaramillo
Christian Lienhardt
Fuad Mirzayev
Mario Raviglione
Fraser Wares
Diana Weil
Karin Weyer
Joël Keravec, Global Drug Facility/TBP

Department of HIV/AIDS

Marco Vitoria

Essential Medicines and Pharmaceutical Policies (EMP)

Lembit Rägo

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK299540

Contents

< Prev Next >

PubReader
Print View
Cite this Page
The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. Geneva: World Health Organization; 2014. Annex 1, List of WHO guideline Steering Group members.
PDF version of this title (531K)